The 2004 Fierce 15: Where are they now?

FierceBiotech Fierce 15 Winners

Last week we brought you the first installment of our look back at the fates of our first-ever list of Fierce 15 companies. Now we're turning our attention to the Fierce 15 of 2004. Some companies on this list--CombinatoRx, FivePrime and Micromet, to name a few--have fared quite well over the years, while others have faded to black. For all their stories, take a look at this list.

  • ARYx
  • CombinatoRx
  • Corus Pharma
  • Cyberkinetics
  • Deltanoid
  • Diatos
  • Eximias
  • FivePrime Therapeutics
  • Genomic Health
  • Idenix Pharmaceuticals
  • Kalypsys
  • Kereos
  • Micromet
  • Synta Pharmaceuticals
  • Therion Biologics


Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.